XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The following table presents a summary of the revenues and adjusted EBITDA of our three operating segments for the three months ended March 31, 2023 and 2022:
Three Months Ended March 31,
(In thousands)20232022
Revenues by segment:
RCM$48,631 $40,511 
EHR
Recurring revenue
Acute EHR27,613 27,364 
Post-acute EHR3,906 3,895 
Total recurring EHR revenue31,519 31,259 
Non-recurring revenue
Acute EHR3,292 3,028 
Post-acute EHR380 476 
Total non-recurring EHR revenue3,672 3,504 
Total EHR revenue$35,191 $34,763 
Patient engagement2,411 2,597 
Total revenues$86,233 $77,871 
Adjusted EBITDA by segment:
RCM$7,898 $9,581 
EHR6,157 6,163 
Patient engagement588 409 
Total adjusted EBITDA$14,643 $16,153 
Reconciliation Of Net Income From Continuing Operations To Adjusted Income (Loss) From Before Interest, Taxes, Depreciation And Amortization The following table reconciles net income to adjusted EBITDA:
Three Months Ended March 31,
(In thousands)20232022
Net income, as reported$3,084 $8,113 
Deferred revenue and other acquisition-related adjustments— 79 
Depreciation expense498 578 
Amortization of software development costs1,486 526 
Amortization of acquisition-related intangibles4,014 3,672 
Stock-based compensation1,247 1,717 
Severance and other non-recurring charges1,104 594 
Interest expense and other, net2,401 761 
(Gain)/Loss on contingent consideration— (1,250)
Provision for income taxes809 1,363 
Total adjusted EBITDA$14,643 $16,153